TherapeuticsMD, Inc. (TXMD) Financials
TXMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 50.5 million | 22.4 million |
2023-06-30 | 53.7 million | 22.5 million |
2023-03-31 | 90.5 million | 55.3 million |
2022-12-31 | 809040 | 49186 |
TXMD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.0 million | 234000 |
2023-06-30 | -3.4 million | 438000 |
2023-03-31 | 59.7 million | 3.0 million |
2022-12-31 | 30706 | 3.0 million |
TXMD Net Income
No data available :(
TXMD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 10.2 million | - | 8.2 million |
2023-06-30 | 13.7 million | - | 8.4 million |
2023-03-31 | 38.1 million | - | 8.6 million |
2022-12-31 | 363148 | - | 8.8 million |
TXMD Shares Outstanding
TXMD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | - | 1.6 million | - |
2023-06-30 | 10000 | - | 2.8 million | - |
2023-03-31 | 37000 | 4.1 million | 2.5 million | 61.7 million |
2022-12-31 | 10000 | 4.1 million | 59.2 million | - |
TXMD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | -53000 | 130000 |
2023-06-30 | 437000 | 128000 |
2023-03-31 | 1.2 million | 3.4 million |
2022-12-31 | 103108 | 29735 |
TXMD
Price: $1.88
52 week price:
Earnings Per Share: 4.85 USD
P/E Ratio: 0.46
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 688
Ebitda: -21.6 millionMarket Capitalization: 22.3 million